Sort
326,823 grants matching “clinical trial”
A STUDY TO ASSESS EFFICACY, SAFTETY AND PHARMACOKINETICS OF EYU688 IN HEALTHY PARTICIPANTS CHALLENGED WITH DENGUE SEROTYPE 2
$3,096,871Anna Palmer Durbin · Johns Hopkins University · N01 · FY2023 · AI
Optimizing HIV prevention for high-risk methamphetamine-using men who have sex with men
$3,096,599Christian Grov · Graduate School Of Public Health And Health Policy · UH3 · FY2025 · AI
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICS
$3,096,387Michael S. Saag · University Of Alabama At Birmingham · R24 · FY2009 · AI
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$3,096,310Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
HIV, Depression, and Insulin Resistance
$3,096,280Samir Kumar Gupta · Indiana University Indianapolis · R01 · FY2025 · DK
Michigan Cancer Research Consortium NCORP
$3,096,276Tareq Al Baghdadi · Saint Joseph Mercy Health System · UG1 · FY2023 · CA
Virginia Mason/UCHSC Autoimmune Prevention Center
$3,096,127University Of Colorado Denver · U19 · FY2004 · AI
PREVENTION OF EVENTS WITH ACE INHIBITORS--CLINICAL TRIAL
$3,096,000George Washington University · N01 · FY2000 · HC
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$3,094,983Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
$3,094,647Social And Scientific Systems, Inc. · U01 · FY2001 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) â Mix & Match DMID #21-0012 {Supplement #7}
$3,094,264David S Stephens · Emory University · UM1 · FY2021 · AI
Randomized Trial of High-Dose Rifampin in Patients with New Smear-Positive TB
$3,094,141Carole D Mitnick · Harvard Medical School · U01 · FY2012 · AI
Indiana Alzheimer's Disease Research Center
$3,093,445Andrew J Saykin · Indiana University Indianapolis · P30 · FY2021 · AG
THAPCA Trials - Scientific Application
$3,093,336Frank W Moler · University Of Michigan At Ann Arbor · U01 · FY2012 · HL
Baylor College of Medicine Cancer Center
$3,092,811C Kent Osborne · Baylor College Of Medicine · P30 · FY2013 · CA
Targets to Therapeutics in Pancreatic Cancer
$3,092,685Translational Genomics Research Inst · P01 · FY2005 · CA
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Laboratory Center
$3,092,246Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2020 · AI
Stanford University Cancer Center
$3,091,618Beverly Shriver Mitchell · Stanford University · P30 · FY2012 · CA
Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes - Biostatistics Research Center
$3,091,578Barbara Halina Braffett · George Washington University · U01 · FY2025 · DK
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD Cohort
$3,091,209Marilyn S Albert · Johns Hopkins University · U19 · FY2014 · AG
Clinical and Translational Science Award
$3,091,207Harry Shamoon · Albert Einstein College Of Medicine, Inc · UL1 · FY2015 · TR
NINDS CENTER FOR CLINICAL TRIAL RESOURCES
$3,091,027Kathryn Hefner · The Emmes Company, Llc · N01 · FY2023 · DA
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
$3,090,708Adnan Iqbal Qureshi · University Of Minnesota · U01 · FY2013 · NS
WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSIS
$3,090,116Emory University · R01 · FY2002 · NS
Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations
$3,089,892Debra P Ritzwoller · Kaiser Foundation Research Institute · UM1 · FY2019 · CA